February 21, 2025

I’m a 2.0 Version of Myself After Cancer

Although there’s no history of breast cancer in my family, when I was 10, my pediatrician introduced me to breast self-exams, so I would become familiar with my breasts and learn to spot any unusual c...

The ASCO Post

February 21, 2025

AAN: Limited Benefits Found for Epidural Steroid Injections

New systematic review from the American Academy of Neurology finds epidural steroid injections offer modest short-term benefits but limited long-term efficacy for treating spinal pain conditions, with varying results across different applications.

Conexiant

February 21, 2025

Exercise Therapy as Candidate Anticancer Strategy

Lee Jones, PhD, Head of the Exercise Oncology Program at Memorial Sloan Kettering Cancer Center, shared findings from an early-phase clinical trial to determine the feasibility, safety, and tumor biol...

The ASCO Post

February 21, 2025

ADA urges CMS to improve supplemental dental benefit oversight in Medicare Advantage

The ADA has urged the Centers for Medicare & Medicaid Services to strengthen protections for Medicare Advantage beneficiaries.

ADA News

February 21, 2025

Cancer Mortality Rates Continue to Decline, Incidence Rates in Women Rise, and Racial Disparities Persist

The findings in the American Cancer Society (ACS) annual report, Cancer Statistics, 2025,1 showed a mixed trend in cancer incidence and mortality rates. Although cancer mortality declined by 34% from ...

The ASCO Post

February 12, 2025

FDA Approves Brentuximab Vedotin With Lenalidomide and Rituximab for Relapsed or Refractory LBCL

The FDA has approved brentuximab vedotin (Adcetris) in combination with lenalidomide and a rituximab product for adult patients with relapsed or refractory large B-cell lymphoma (LBCL)—including diffu...

The ASCO Post

February 11, 2025

FDA Approves Acalabrutinib With Bendamustine and Rituximab for Previously Untreated Mantle Cell Lymphoma

On January 16, the U.S. Food and Drug Administration (FDA) granted traditional approval to acalabrutinib (Calquence) with bendamustine and rituximab for adults with previously untreated mantle cell ly...

The ASCO Post

February 06, 2025

ASE Updates Vascular Access Ultrasound Guidelines

New recommendations from the American Society of Echocardiography strongly endorse ultrasound guidance for most vascular access procedures while acknowledging evidence gaps.

Conexiant

February 05, 2025

ADA scholarships support dentists interested in academia

Seven scholarships are available for a teacher training program for dental educators and private practitioners interested in academics.

ADA News